Clinical TrialsSearch results
Number of results: 693
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Other
- A Phase II trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancer
- Locally advanced pancreatic cancer
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- 2006-09-12
Other
- Prevention of metastasis by an ultra-short acting and the most selective beta1 blocker, Landiolol
- non-small cell lung cancer
- Hida Yasuhiro
- 2019-01-17
Recruiting
- Long-term follow-up study after 'Treatment of lumbar canal stenosis with a combination of ultra-purified, allogenic, bone marrow-derived, mesenchymal stem cells (REC) and in situ-forming gel: a multicentre, prospective, double blind, randomised, controlled trial'
- Combined lumbar canal stenosis
- Hideki Sudo
- 2023-04-29
Completed
- Neoadjuvant nab-paclitaxel plus gemcitabine therapy for resectable pancreatic cancer; A phase II multicenter trial
- Pancreatic ductal adenocarcinoma
- Hirano Satoshi
- 2019-03-27
Recruiting
- PHE885 CAR-T therapy in adult participants with relapsed and refractory multiple myeloma
- Multiple myeloma
- Hirano Takamitsu
- 2022-07-25
Recruiting
- Expanded Access Program of ONO-7702/ONO-7703 (ONO-7702/7703-03E)
- Radically unresectable BRAF V600-mutant thyroid cancer
- Hirashima Yoshinori
- 2023-08-23
Completed
- Efficacy and safety of oral semaglutide 50 mg once daily in East Asian participants with overweight or obesity (NN9932-4738, OASIS 2)
- Obesity
- Hirose Ryoma
- 2021-11-26
Other
- A phase I/II study of weekly paclitaxel therapy for metastatic gastric cancer (Step 2)
- Fluoropyrimidine failure metastatic gastric cancer
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01